Kathleen Nelson. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » AnimalsAntineoplastic Agents/pharmacologyNeoplasms, Experimental/pathologyPyruvates/pharmacologyPyruvates/therapeutic use
Substances: See more » Antineoplastic AgentsPyruvatesbromopyruvate
Year: 2002 PMID: 12217784 DOI: 10.1016/s1470-2045(02)00867-7
Source DB: PubMed Journal: Lancet Oncol ISSN: 1470-2045 Impact factor: 41.316